Wednesday, November 01, 2006 6:00:00 AM PDT | VentureDeal Staff
Endovascular treatment designer Pathway
Medical Technologies has announced the closing of a $25 million Series B
round of financing.
Two new investors joined the round as did existing investors. The company
is developing what it calls a Pathway Atherectomy System that treats patients
diagnosed with Peripheral Arterial Disease (PAD).
The company is still in early clinical stage and will likely use the funds to
advance its product through additional clinical trials.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
Email Sign Up
© 2014 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.